SENP1 Aberrance and Its Linkage to Clinical Features, Adjuvant Regimen, and Prognosis in Patients With Surgical Non-small Cell Lung Cancer Receiving Adjuvant Chemotherapy

SENP1 Aberrance and Its Linkage to Clinical Features, Adjuvant Regimen, and Prognosis in Patients With Surgical Non-small Cell Lung Cancer Receiving Adjuvant Chemotherapy

BackgroundSmall ubiquitin-like modifier-specific protease 1 (SENP1) plays vital roles in cancer progression and chemoresistance, but its prognostic value in non-small cell lung cancer (NSCLC) is vague. This study aimed to explore the correlation of SENP1 with clinical features, adjuvant chemotherapy...

Full description

Bibliographic Details
Main Authors:	Qian Yang, Mengmeng Yang, Jun Zhang, Yuquan Ma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Surgery
Subjects:	small ubiquitin-like modifier-specific protease 1 surgical non-small cell lung cancer clinical features adjuvant chemotherapy regimen prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fsurg.2021.771785/full

Similar Items

Adjuvant Chemotherapy in Elderly Patients with Early-stage Non-small Cell Lung Cancer
by: Umut KEFELİ, et al.
Published: (2019-10-01)

Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy
by: Ping Chen, et al.
Published: (2022-09-01)

SENP8 limits aberrant neddylation of NEDD8 pathway components to promote cullin-RING ubiquitin ligase function
by: Kate E Coleman, et al.
Published: (2017-05-01)

NopD of Bradyrhizobium sp. XS1150 Possesses SUMO Protease Activity
by: Qi-Wang Xiang, et al.
Published: (2020-03-01)

Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
by: Katsurada N, et al.
Published: (2020-02-01)

Influence of Programmed Death Ligand-1-Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy
by: Zhao M, et al.
Published: (2020-08-01)

Small bowel adenocarcinomas with favorable prognoses by radical resection and adjuvant chemotherapy: a case series of five cases
by: Yuri Nishioka, et al.
Published: (2023-10-01)

Effect of Adjuvant and Palliative Chemotherapy in Large Cell Neuroendocrine Carcinoma of the Lung: A Systematic Review and Meta-Analysis
by: Hao Chen, et al.
Published: (2021-11-01)

Small GTPase—A Key Role in Host Cell for Coronavirus Infection and a Potential Target for Coronavirus Vaccine Adjuvant Discovery
by: Wei Hou, et al.
Published: (2022-09-01)

Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
by: Emilia Montagna, et al.
Published: (2020-10-01)

Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
by: Zi-Qing Shen, et al.
Published: (2024-01-01)

Value of adjuvant chemotherapy for patients with pT2N0M0 non‐small cell lung cancer receiving radical resection
by: Shiqi Chen, et al.
Published: (2024-01-01)

Update on adjuvant therapy in completely resected NSCLC patients
by: Jeong Uk Lim, et al.
Published: (2022-02-01)

Prospects for the development of adjuvant therapy for non-small cell lung cancer
by: K. K. Laktionov, et al.
Published: (2020-11-01)

Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
by: Wanjing Chen, et al.
Published: (2021-02-01)

Prediction of disease-free survival of N1/2 non-small cell lung cancer after adjuvant chemotherapy by the biomarker RPMB
by: Ning An, et al.
Published: (2023-07-01)

In Vivo Removal of N-Terminal Fusion Domains From Recombinant Target Proteins Produced in Nicotiana benthamiana
by: Md Reyazul Islam, et al.
Published: (2020-04-01)

Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy
by: Jia X, et al.
Published: (2023-03-01)

Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis
by: Kiichi Sugimoto, et al.
Published: (2021-04-01)

Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis
by: Miriam Blasi, et al.
Published: (2022-06-01)

Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix
by: Ting Shen, et al.
Published: (2019-11-01)

Augmenting Anti-Cancer Natural Products with a Small Molecule Adjuvant
by: Paul G. Wahome, et al.
Published: (2014-12-01)

Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: a retrospective observational study with use of a national database in Japan
by: Hirokazu Urushiyama, et al.
Published: (2017-09-01)

Updated Adjuvant Chemotherapy for Gastric Cancer
by: Toshizo Takayama, et al.
Published: (2023-10-01)

Prognostic model for the exemption of adjuvant chemotherapy in stage IIIC endometrial cancer patients
by: Xi-Lin Yang, et al.
Published: (2022-10-01)

Adjuvant therapy and prognosis in uterine carcinosarcoma
by: Chi-Yuan Chiang, et al.
Published: (2021-11-01)

Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components
by: Ying Li, et al.
Published: (2024-02-01)

Adjuvant chemotherapy for gastric cancer
by: I. P. Kolesnyk, et al.
Published: (2015-12-01)

USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective
by: Georgiy Korenev, et al.
Published: (2022-11-01)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
by: Bengt Glimelius, et al.
Published: (2020-08-01)

Adjuvant Chemotherapy for Stage III Colon Cancer
by: Julien Taieb, et al.
Published: (2020-09-01)

ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Current advances in the selection of adjuvant radiotherapy regimens for keloid
by: Weihao Wang, et al.
Published: (2022-11-01)

Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States
by: Wentao Tian, et al.
Published: (2023-09-01)

Protein Stability of Pyruvate Kinase Isozyme M2 Is Mediated by HAUSP
by: Hae-Seul Choi, et al.
Published: (2020-06-01)

Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study
by: Long Liang, et al.
Published: (2022-08-01)

Recent Advances in Adjuvant Therapy for Non–Small-Cell Lung Cancer
by: Mi-Hyun Kim, et al.
Published: (2024-01-01)

Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer—Clinical Trials Experience
by: Izabela Chmielewska, et al.
Published: (2021-10-01)

Adjuvant targeted therapy for non-small cell lung cancer
by: Konstantin K. Laktionov, et al.
Published: (2020-07-01)

Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis
by: Xinyu Wang, et al.
Published: (2018-11-01)